iC³ Summit Early-Bird Discounts End Friday, September 6
|
Whether on the stage, attending an informative session or exhibiting we invite all Summit attendees to accelerate your networking and use our Partnering Platform this year.
|
Book Your Stay at the Loews Arlington Hotel for the iC³ Summit
|
Maximize your iC³ Summit experience and stay at the Loews Arlington Hotel! Enjoy the convenience of being just steps away from all Summit sessions and networking opportunities! Bring the family to Arlington for the summer of a lifetime!
|
BioNTX Breakfast of Champions
|
More Rising Stars Emerge: Class of 2024 iC³ Summit
|
Congratulations GenrAb and Panthera BioSolutions
BioNTX is proud to continue its legacy of showcasing innovative companies at the iC³ Life Science Summit. This platform highlights exceptional Texas-based companies with no more than $100 million in funding or revenue, making strides in solving critical challenges in health, pharma, and biosciences. Join us in 2024 as we support and celebrate these rising stars.
|
BioNTX Announces Finalist of 3rd Annual Tech Transfer Showcase
|
Thin-Film Electrodes on Softening Polymers for Spinal Cord Stimulation
|
Advanced Non-Contact Vital Sign Monitoring with Multi-View Doppler Technology
|
Genetically Primed Therapeutic MSCs
|
Unlocking the healing power of the binding of intracellular proteins to voltage-gated sodium channels for mental illness
|
Endovascular surgical guidewire with ultrasound localization
|
BioNTX is thrilled to announce the applicants advancing to the next round of our 3rd Annual Tech Transfer Showcase. These outstanding innovators have demonstrated exceptional potential, and their technologies will undergo further evaluation as they move closer to the final competition. Finalists will showcase their groundbreaking work at the iC³ Summit on Friday, October 4th where the final winners will be announced.
The showcase underscores the impressive advancements in science emerging from Texas, highlighting our state's leading role in driving innovation and excellence in the field.
|
Connect with the Best: Top Innovators, Visionary Thought-Leaders, and Game-Changers at iC³ 2024
|
Celebrating a Decade of Innovation and Excellence in North Texas
|
2024 EY Texas Report: Building Biotech in Texas
|
Transforming Healthcare with AI & SMART Medical Devices
|
Delve into the latest trends and pressing issues with combining AI/Machine learning into medical devices, with a focus on product design, development and manufacturing, intellectual property, cybersecurity and validation as well as differences in regulatory and clinical pathways for Class I, II and III devices.
Hear visionaries and experts share their experiences and strategies to navigate these challenges to successfully bringing new medical devices to market.
|
Startup Trends in an Emerging Market
|
An in-depth discussion of the latest trends and key issues in developing biotech facilities in our region, including wet labs, incubators, and innovation hubs.
Gain valuable insights into the design, management, and operation of these specialized spaces, essential for driving innovation and advancing biotechnology research.
|
Next Generation of Cell & Gene Therapy in Texas Today
|
Explore the cutting-edge trends and pressing issues in cell and gene therapy, with a focus on the readiness of Texas to support research and development in this transformative field. Gain insights into the latest scientific advancements, regulatory challenges, and infrastructural needs for conducting cell and gene therapy research. Learn Texas' current capabilities, potential opportunities, and strategic initiatives to position the state as a leader in cell and gene therapy innovation.
|
iC³ Sponsor Spotlight: 82VS
|
82VS, Alloy Therapeutics' affiliated venture studio, combines Alloy’s platforms with a team of experts to launch new asset-centric companies. Alloy partners with top founders, entrepreneurs, and biotech firms to develop innovative medicines and treatments for cancer, neurodegeneration, autoimmune diseases, hereditary blindness, and more.
|
iC³ Sponsor Spotlight: LPA
|
Since 1965, LPA has been dedicated to creating timeless, sustainable designs that enrich the environment, add lasting value, and improve the human experience with a mission to innovate, inspire, and positively impact lives through every project.
With a culture rooted in creativity and collaboration, LPA develops high-performing solutions for challenging environments in life sciences, physical sciences, and advanced technology facilities; working closely with clients to design inspiring, sustainable, and functional laboratory spaces that support scientific discovery and a better future.
|
iC³ Sponsor Spotlight: Fragomen
|
Fragomen is a leading firm dedicated to immigration services worldwide with over 5,500 immigration professionals and support staff in more than 60 offices across the Americas, EMEA and Asia Pacific. A member of the Am Law 100 and Am Law Global 100, Fragomen offers immigration support in more than 170 countries.
|
iC³ Sponsor Spotlight: Dallas College
|
Dallas College is one of the largest community colleges in Texas. Since 1965, we have helped almost 3 million people on their educational journey.
The College works to ensure that Dallas County is vibrant, growing, and economically viable for future generations. Students benefit from partnerships with local business leaders, school districts and four-year universities. In addition, Dallas College provides economic benefits to business, taxpayers and the community.
|
iC³ Sponsor Spotlight: WuXi STA
|
WuXi STA, an integral part of WuXi AppTec, is an industry-leading pharmaceutical development and manufacturing capability and technology platform serving the life sciences industry with operations across Asia, North America and Europe.
A leading Contract Development, and Manufacturing Organization (CDMO), WuXi STA offers efficient, flexible, and high-quality solutions for integrated development and manufacturing from preclinical to commercial.
|
Thank You 2024 iC³ Sponsors!
|
|
